{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:13:51Z","timestamp":1760148831096,"version":"build-2065373602"},"reference-count":56,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Background: The arterial pathology and mechanisms of increased cardiovascular disease (CVD) risk in HCV-infected individuals are not yet clear. The aim of this study was to identify types of arterial pathology in treatment-naive chronic HCV patients and to test their reversibility after successful treatment. Methods: Consecutive, never-treated, HCV-infected patients were compared with age and CVD-related risk factors, matched controls, healthy individuals (HI), patients with rheumatoid arthritis (RA) and people living with HIV (PLWH), in terms of arterial stiffening by pulse wave velocity, arterial atheromatosis\/hypertrophy by carotid plaques\/intima-media thickness and impaired pressure wave reflections by augmentation index. After three months of sustained virological response (SVR) administered using direct-acting antivirals, vascular examination was repeated in HCV-infected patients to test drug and viral-elimination effect in subclinical CVD. Results: Thirty HCV patients were examined at baseline; fourteen of them were re-examined post-SVR. Compared with HI, HCV patients had significantly more plaques, which is similar to that of RA patients and the PLWH group. No other differences were found in all other vascular biomarkers, and regression among HCV patients also revealed no differences 3 months post-SVR. Conclusions: Accelerated atheromatosis, rather than arterial stiffening, arterial remodeling and peripheral impaired hemodynamics is the underlying pathology leading to increased CVD risk in HCV patients.<\/jats:p>","DOI":"10.3390\/v15061374","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T01:32:57Z","timestamp":1686792777000},"page":"1374","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Comparative Study on the Presence and Reversibility of Subclinical Arterial Damage in HCV-Infected Individuals and Matched Controls"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2556-6230","authenticated-orcid":false,"given":"Theodoros","family":"Androutsakos","sequence":"first","affiliation":[{"name":"Clinic\/Laboratory of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Mouziouras","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Laiko General Hospital, School of Medicine, National and Kapodistrian University Athens, 11527 Athens, Greece"},{"name":"Cardiovascular Prevention and Research Unit, Clinic\/Laboratory of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4481-9993","authenticated-orcid":false,"given":"Stamatia","family":"Katelani","sequence":"additional","affiliation":[{"name":"Clinic\/Laboratory of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3000-8447","authenticated-orcid":false,"given":"Mina","family":"Psichogiou","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Laiko General Hospital, School of Medicine, National and Kapodistrian University Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petros P.","family":"Sfikakis","sequence":"additional","affiliation":[{"name":"First Department of Propaedeutic Medicine, Laiko General Hospital, School of Medicine, National and Kapodistrian University Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3825-532X","authenticated-orcid":false,"given":"Athanase D.","family":"Protogerou","sequence":"additional","affiliation":[{"name":"Clinic\/Laboratory of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece"},{"name":"Cardiovascular Prevention and Research Unit, Clinic\/Laboratory of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8906-6959","authenticated-orcid":false,"given":"Antonios A.","family":"Argyris","sequence":"additional","affiliation":[{"name":"Cardiovascular Prevention and Research Unit, Clinic\/Laboratory of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.12998\/wjcc.v6.i13.589","article-title":"Update on global epidemiology of viral hepatitis and preventive strategies","volume":"6","author":"Jefferies","year":"2018","journal-title":"World J. Clin. Cases"},{"key":"ref_2","unstructured":"WHO (2023, February 28). Global Hepatitis Programme. Global Hepatitis Report 2017. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789241565455."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.7326\/M16-2575","article-title":"Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review","volume":"166","author":"Nelson","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"17006","DOI":"10.1038\/nrdp.2017.6","article-title":"Hepatitis C virus infection","volume":"3","author":"Manns","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_5","first-page":"189","article-title":"Efficacy, Safety, and Predictors of Direct-acting antivirals in Hepatitis C Virus Patients with Heterogeneous Liver Diseases","volume":"42","author":"Morelli","year":"2019","journal-title":"New Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11886-021-01475-6","article-title":"Atherosclerotic Cardiovascular Disease in Individuals with Hepatitis C Viral Infection","volume":"23","author":"Bailey","year":"2021","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.14218\/JCTH.2017.00021","article-title":"Risk of Cardiovascular Disease Due to Chronic Hepatitis C Infection: A Review","volume":"5","author":"Babiker","year":"2017","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jhep.2018.02.015","article-title":"Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis","volume":"69","author":"Petta","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11739-019-02163-8","article-title":"Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: A prospective cohort study","volume":"15","author":"Ambrosino","year":"2020","journal-title":"Intern. Emerg. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/jvh.13406","article-title":"Persistent augmentation of central arterial stiffness following viral clearance by direct-acting antivirals in chronic hepatitis C","volume":"28","author":"Chen","year":"2021","journal-title":"J. Viral. Hepat."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.2169\/internalmedicine.1514-18","article-title":"Carotid Intima-media Thickness and Small Dense Low-density Lipoprotein Cholesterol Increase after One Year of Treatment with Direct-acting Antivirals in Patients with Hepatitis C Virus Infection","volume":"58","author":"Ichikawa","year":"2019","journal-title":"Intern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijcard.2018.04.058","article-title":"Interferon- and ribavirin-free therapy with new direct acting antivirals (DAA) for chronic hepatitis C improves vascular endothelial function","volume":"271","author":"Schmidt","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"European Association for Study of Liver, and Asociacion Latinoamericana para el Estudio del Higado (2015). EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J. Hepatol., 63, 237\u2013264.","DOI":"10.1016\/j.jhep.2015.04.006"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1097\/HJH.0000000000001961","article-title":"2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH\/ESC Task Force for the Management of Arterial Hypertension","volume":"36","author":"Williams","year":"2018","journal-title":"J. Hypertens."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2020). EASL recommendations on treatment of hepatitis C: Final update of the series\u2606. J. Hepatol., 73, 1170\u20131218. published correction appears in J. Hepatol. 2023, 78, 452.","DOI":"10.1016\/j.jhep.2022.10.006"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/0003319718801093","article-title":"Prevalence, Incidence, and Contributors of Subclinical Atheromatosis, Arteriosclerosis, and Arterial Hypertrophy in HIV-Infected Individuals: A Single-Center, 3-Year Prospective Study","volume":"70","author":"Psichogiou","year":"2019","journal-title":"Angiology"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Protogerou, A.D., Fransen, J., Zampeli, E., Argyris, A.A., Aissopou, E., Arida, A., Konstantonis, G.D., Tentolouris, N., Makrilakis, K., and Psichogiou, M. (2015). The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132307"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/QAI.0000000000002286","article-title":"Progression of Subclinical Vascular Damage in People Living With HIV Is Not Predicted by Current Cardiovascular Risk Scores: A Prospective 3-Year Study","volume":"83","author":"Kapelios","year":"2020","journal-title":"J. Acquir. Immune DeficSyndr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/aid.2021.0015","article-title":"Detection of Subclinical Coronary Artery Lesions by Framingham Risk Score, Peripheral Artery Atheromatosis and Coronary Artery Calcium Score: A Pilot Study in Asymptomatic Individuals Living with HIV","volume":"37","author":"Kapelios","year":"2021","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"R44","DOI":"10.1186\/ar3757","article-title":"Predictors of new atherosclerotic carotid plaque development in patients with rheumatoid arthritis: A longitudinal study","volume":"14","author":"Zampeli","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1136\/annrheumdis-2011-201278","article-title":"Subclinical femoral atheromatosis in rheumatoid arthritis: Comparable prevalence to diabetes mellitus in a case-control study","volume":"71","author":"Protogerou","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/hiv.13166","article-title":"Cardiac adiposity as a modulator of cardiovascular disease in HIV","volume":"22","author":"Bonou","year":"2021","journal-title":"HIV Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.atherosclerosis.2010.11.013","article-title":"Markers of atherosclerosis and inflammation and mortality in patients with HIV infection","volume":"214","author":"Mangili","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/QAI.0B013E31822D4993","article-title":"HIV infection and progression of carotid and coronary atherosclerosis: The CARE study","volume":"58","author":"Mangili","year":"2011","journal-title":"J. Acquir. Immune DeficSyndr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1093\/rheumatology\/keu224","article-title":"Cardiovascular risk in rheumatoid arthritis: Recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment","volume":"53","author":"Choy","year":"2014","journal-title":"Rheumatology"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Arida, A., Protogerou, A.D., Kitas, G.D., and Sfikakis, P.P. (2018). Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19071890"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1093\/eurheartj\/ehl254","article-title":"Expert consensus document on arterial stiffness: Methodological issues and clinical applications","volume":"27","author":"Laurent","year":"2006","journal-title":"Eur. Heart J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.atherosclerosis.2015.05.007","article-title":"The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society","volume":"241","author":"Vlachopoulos","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/eurheartj\/14.2.160","article-title":"An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man","volume":"14","author":"Karamanoglu","year":"1993","journal-title":"Eur. Heart J."},{"key":"ref_32","unstructured":"StataCorp (2021). Stata User\u2019s Guide, in Version 13.0, Stata Press."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.gastro.2015.09.007","article-title":"Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies","volume":"150","author":"Petta","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.atherosclerosis.2013.08.003","article-title":"Chronic HCV infection is a risk factor of ischemic stroke","volume":"231","author":"Adinolfi","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/599371","article-title":"Hepatitis C virus infection and the risk of coronary disease","volume":"49","author":"Butt","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.amjcard.2014.09.020","article-title":"Impact of hepatitis C seropositivity on the risk of coronary heart disease events","volume":"114","author":"Pothineni","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4254\/wjh.v5.i10.528","article-title":"Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations","volume":"5","author":"Zampino","year":"2013","journal-title":"World J. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1053\/gast.2002.30983","article-title":"Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein","volume":"122","author":"Okuda","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(02)07339-7","article-title":"Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening","volume":"359","author":"Ishizaka","year":"2002","journal-title":"Lancet"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1253\/circj.67.26","article-title":"Association between hepatitis C virus core protein and carotid atherosclerosis","volume":"67","author":"Ishizaka","year":"2003","journal-title":"Circ. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jcmg.2013.11.014","article-title":"Carotid intima-media thickness and plaque in cardiovascular risk assessment","volume":"7","author":"Naqvi","year":"2014","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"k1036","DOI":"10.1136\/bmj.k1036","article-title":"Increased cardiovascular risk in rheumatoid arthritis: Mechanisms and implications","volume":"361","author":"England","year":"2018","journal-title":"BMJ"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1016\/S2352-3018(20)30036-9","article-title":"HIV and cardiovascular disease","volume":"7","author":"Benjamin","year":"2020","journal-title":"Lancet HIV"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrrheum.2011.168","article-title":"Cardiovascular safety of biologic therapies for the treatment of RA","volume":"8","author":"Greenberg","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11883-012-0295-3","article-title":"Moving beyond JUPITER: Will inhibiting inflammation reduce vascular event rates?","volume":"15","author":"Ridker","year":"2013","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clim.2018.12.011","article-title":"Autoimmune and angiogenic biomarkers in autoimmune atherosclerosis","volume":"199","author":"Balogh","year":"2019","journal-title":"Clin. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/liv.13589","article-title":"The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis","volume":"38","author":"Bendtsen","year":"2018","journal-title":"Liver Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1161\/01.HYP.33.5.1111","article-title":"Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients","volume":"33","author":"Blacher","year":"1999","journal-title":"Hypertension"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/hy0102.099031","article-title":"Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: A longitudinal study","volume":"39","author":"Boutouyrie","year":"2002","journal-title":"Hypertension"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/01.HYP.37.5.1236","article-title":"Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients","volume":"37","author":"Laurent","year":"2001","journal-title":"Hypertension"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1161\/CIRCULATIONAHA.104.483628","article-title":"Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults","volume":"111","author":"Najjar","year":"2005","journal-title":"Circulation"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Reference Values for Arterial Stiffness\u2019 Collaboration (2010). Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: \u2018establishing normal and reference values\u2019. Eur. Heart J., 31, 2338\u20132350.","DOI":"10.1093\/eurheartj\/ehq165"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000343145","article-title":"Mannheim carotid intima-media thickness and plaque consensus (2004\u20132006\u20132011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany","volume":"34","author":"Touboul","year":"2012","journal-title":"Cerebrovasc. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1001\/jama.2012.9630","article-title":"Common carotid intima-media thickness measurements in cardiovascular risk prediction: A meta-analysis","volume":"308","author":"Peters","year":"2012","journal-title":"JAMA"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1093\/eurheartj\/ehs380","article-title":"Reference intervals for common carotid intima-media thickness measured with echotracking: Relation with risk factors","volume":"34","author":"Engelen","year":"2013","journal-title":"Eur. Heart J."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/6\/1374\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:55:15Z","timestamp":1760126115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/6\/1374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":56,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["v15061374"],"URL":"https:\/\/doi.org\/10.3390\/v15061374","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2023,6,15]]}}}